Global Erythropoietin Stimulating Agents Market 2024-2028
상품코드:1580868
리서치사:TechNavio
발행일:2024년 10월
페이지 정보:영문 137 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
에리스로포이에틴 자극제 시장, 2024-2028년
에리스로포이에틴 자극제 시장은 2023-2028년에 45억 540만 달러, 예측 기간 중 CAGR은 8.5%로 성장할 것으로 예측됩니다. 에리스로포이에틴 자극제 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 이 시장은 다수의 CKD 환자의 존재, HIV 감염증 및 말기 신장 장애에서 용도의 증가, 수술중 혈전증의 리스크, 순적혈구 무형성증 등이 촉진하고 있습니다.
시장 범위
기준년
2024년
종료년
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
전년대비[2024년]
7.7%
CAGR
8.5%
증분액
45억 540만 달러
본 조사에서는 신흥 경제국에서 CKD 투석 센터의 증가를 향후 수년간 에리스로포이에틴 자극제 시장 성장을 촉진하는 주요인의 하나로 식별하고 있습니다. 또한 벤더간 전략적 제휴의 증가 및 개량형 에리스로포이에틴 제제를 개발하기 위한 연구개발 투자의 증가도 시장의 큰 수요로 연결될 것으로 생각되고 있습니다.
The erythropoietin stimulating agents market is forecasted to grow by USD 4505.4 mn during 2023-2028, accelerating at a CAGR of 8.5% during the forecast period. The report on the erythropoietin stimulating agents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by presence of large pool of ckd patients, rising applications in hiv infections and end-stage renal disorder, and risks of thrombosis, during surgeries, and pure red cell aplasia.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
7.7%
CAGR
8.5%
Incremental Value
$4505.4 mn
Technavio's erythropoietin stimulating agents market is segmented as below:
By Type
Epoetin alfa
Epoetin beta
Darbepoetin alfa
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the growing number of ckd dialysis centers in developing economies as one of the prime reasons driving the erythropoietin stimulating agents market growth during the next few years. Also, increasing instances of strategic collaborations among vendors and increasing investments in research and development for developing new and improved erythropoietin products will lead to sizable demand in the market.
The report on the erythropoietin stimulating agents market covers the following areas:
Erythropoietin Stimulating Agents Market sizing
Erythropoietin Stimulating Agents Market forecast
Erythropoietin Stimulating Agents Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading erythropoietin stimulating agents market vendors that include 3SBio Inc., Akebia Therapeutics, Amgen Inc., Biocon Ltd., Biosidus SA, Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Nanogen Pharmaceutical Biotechnology, NephroPlus, Novartis AG, Pfizer Inc., Reliance Industries Ltd., Renal Project, Thermo Fisher Scientific Inc., and Zydus Lifesciences Ltd.. Also, the erythropoietin stimulating agents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Erythropoietin Stimulating Agents Market 2018 - 2022
Historic Market Size - Data Table on Global Erythropoietin Stimulating Agents Market 2018 - 2022 ($ million)
